Stock Report

Download full stock data and analysis for free Last Updated: 15-May-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Nutriband Inc (NTRB)

Stock Card factsheet share-fund-plan-icon

$3.59

up-down-arrow $0.09 (2.57%)

As on 14-May-2026 16:00EDT

Market cap

info icon

$44 Mln

Revenue (TTM)

info icon

$2 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

6.8

Div. Yield

info icon

0 %

Nutriband Inc (NTRB) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 3.53 High: 3.59

52 Week Range

Low: 3.42 High: 11.68

Liquidityliquidity Moderate

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -1.4 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    -4.6

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $--

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    12,155,983

9 Years Aggregate

CFO

$-12.01 Mln

EBITDA

$-17.47 Mln

Net Profit

$-30.88 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Nutriband Inc (NTRB)
-20.9 -9.8 -12.7 -37.3 3.3 -23.6 --
BSE Sensex*
-11.1 -2.1 -8.9 -7.5 6.6 9.1 11.4
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 14-May-2026  |  *As on 15-May-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2022
2021
2020
2019
Nutriband Inc (NTRB)
-3.6 101.8 -35.6 -51.3 -32.8 7.1 -58.9
S&P Small-Cap 600
4.0 7.0 13.9 -17.4 25.3 9.6 20.9
BSE Sensex
9.1 8.1 18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
Quarterly Annual

*All values are in ($ Mln)

Annual

*All values are in ($ Mln)

Annual

*All values are in ($ Mln)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Peers

View Details
Company
 Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Nutriband Inc (NTRB)
3.6 44.4 2.0 -8.2 -408.4 -125.6 -- 6.8
Agilent Technologies (A)
113.3 31,498.9 7,065.0 1,290.0 21.8 19.4 24.6 4.7
Cooper Companies Inc (COO)
60.4 11,507.9 4,151.9 401.4 11.1 4.8 29.3 1.4
Haemonetics (HAE)
57.1 2,427.7 1,334.0 97.3 14.4 11.4 14.4 2.8
Heart Test Laboratories Inc. (HSCS)
1.9 6.2 0.0 -8.5 -89,802.3 -292.9 -- 2.3
Medtronic PLC (MDT)
77.0 95,700.8 35,484.0 4,614.0 17.7 9.5 20.8 2.0
Veeva Systems Inc. Class A (VEEV)
156.3 26,002.5 3,195.3 908.9 21.0 13.9 29.3 3.8

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Nutriband Inc (NTRB)

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with...  an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company has commercial development and clinical supply agreement with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida. Address: 121 South Orange Avenue, Orlando, FL, United States, 32801  Read more

  • Founder, President, Company Secretary & Executive Chairman of the Board

    Mr. Serguei Melnik

  • Founder, President, Company Secretary & Executive Chairman of the Board

    Mr. Serguei Melnik

  • Headquarters

    Orlando, FL

  • Website

    https://www.nutriband.com

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners
Edit peer-selector-edit

FAQs for Nutriband Inc (NTRB)

The share price of Nutriband Inc (NTRB) is $3.59 (NASDAQ) as of 14-May-2026 16:00 EDT. Nutriband Inc (NTRB) has given a return of 3.32% in the last 3 years.

Since, TTM earnings of Nutriband Inc (NTRB) is negative, P/E ratio is not available.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2026
--
--
2025
--
--
2024
--
--
2023
--
--
2022
--
--

The 52-week high and low of Nutriband Inc (NTRB) are Rs 11.68 and Rs 3.42 as of 15-May-2026.

Nutriband Inc (NTRB) has a market capitalisation of $ 44 Mln as on 12-May-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Nutriband Inc (NTRB), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.